sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> organ transplant immunosuppressant drugs market

report

Organ Transplant Immunosuppressant Drugs Market, by Commercialized Products (Zenapax, Prograf, Cellcept, Myfortic, Neoral), Transplant (Medical Kidney, Bone Marrow, Liver, Heart, Lungs, Others) – Global Revenue, Trends, Growth, Share, Size, and Forecast To 2022

HC286 March 2017 100+ FREE 10% CUSTOMIZATION

To decrease the chances of organ rejection after transplantation the organ transplant immunosuppressant drugs are used. Organ transplant immunosuppressant drugs market is set to grow in the forecast period as there's increasing number of people undergoing transplantation surgeries. North America and Europe are the top consumers of organ transplant immunosuppressant drugs because of advanced healthcare infrastructure and rise of geriatric population. Asia-Pacific is supposed to have a highest growth rate in future for the organ transplant immunosuppressant drugs market because of large population and rapidly improving awareness about these drugs.

The report on the global  organ transplant immunosuppressant drugs market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The key reasons for the growth of organ transplant immunosuppressant drugs market are technological advancements in the field of healthcare, increasing geriatric population, and increase in the cases of organ transplantation.
  • A favorable government policy in healthcare sector is one of the key growth opportunities in the organ transplant immunosuppressant drugs market.
  • However, the organ transplant immunosuppressant drugs market will be hampered by the lack of availability of organs and high cost of transplantation process.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s organ transplant immunosuppressant drugs market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the organ transplant immunosuppressant drugs market by the following segments:

  • Organ Transplant Immunosuppressant Drugs Market, by Commercialized Products
    • Zenapax
    • Prograf
    • Cellcept
    • Myfortic
    • Neoral
  • Organ Transplant Immunosuppressant Drugs Market, by Transplant
    • Medical Kidney
    • Bone Marrow
    • Liver
    • Heart
    • Lungs
    • Others

KEY MARKET PLAYERS

Key players in the organ transplant immunosuppressant drugs market include:

  • Janssen Pharmaceuticals, Inc.
  • Novartis Pharmaceuticals Corporation
  • Pfizer, Inc.
  • Veloxis Pharmaceuticals A/S.
  • Genzyme Corporation (Sanofi S.A.)
  • GlaxoSmithKline plc,
  • AbbVie, Inc.
  • Astellas Pharma, Inc.,
  • F. Hoffmann-La Roche Ltd.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • MIDDLE EAST & AFRICA
    • GCC
    • North Africa
    • South Africa
    • Rest of Middle East & Africa
  • LATIN AMERICA
    • Brazil
    • Rest of Latin America

TRENDING RELATED REPORT

Dermatology Devices Market, by Diagnostic Devices (Dermatoscopes, Microscopes, Imaging Techniques), Treatment Devices (Liposuction, Microdermabrasion, Cryotherapy, Electrosurgical, Light Therapy Devices, Lasers), Applications (Cancer Diagnosis, Wrinkle Removal, Skin Rejuvenation, Skin Resurfacing, Vascular Lesions, Acne, Psoriasis, Hair Removal) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Product Roadmap
  5. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET, BY COMMERCIALIZED PRODUCTS
    1. Segment Share
    2. Commercialized Products
      1. Zenapax
      2. Prograf
      3. Cellcept
      4. Myfortic
      5. Neoral
  6. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET, BY TRANSPLANT
    1. Segment Share
    2. Transplant
      1. Medical Kidney
      2. Bone Marrow
      3. Liver
      4. Heart
      5. Lungs
      6. Others
  7. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET, BY GEOGRAPHY
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Commercialized Products
      3. By Transplant
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K
        4. Rest of Europe
      2. By Commercialized Products
      3. By Transplant
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Commercialized Products
      3. By Transplant
    4. Rest of the World
      1. By Country
        1. Latin America
        2. Middle East & Africa
      2. By Commercialized Products
      3. By Transplant
  8. COMPETITIVE LANDSCAPE
    1. Market Share Analysis, 2015 (%)
    2. Key Innovators
  9. KEY MARKET PLAYERS
    1. Janssen Pharmaceuticals, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Novartis Pharmaceuticals Corporation
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Pfizer, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Veloxis Pharmaceuticals A/S.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Genzyme Corporation (Sanofi S.A.)
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. GlaxoSmithKline plc,
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. AbbVie, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Astellas Pharma, Inc.,
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. F. Hoffmann-La Roche Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
  10. SCALAR 360 DEGREE MARKET PERSPECTIVE
  11. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us